Subcutaneous Vedolizumab Appears to Be Effective Maintenance Therapy in Crohn ' s Disease Subcutaneous Vedolizumab Appears to Be Effective Maintenance Therapy in Crohn ' s Disease

Subcutaneous vedolizumab appears to be an effective and safe maintenance therapy for some patients with moderate to severe active Crohn ' s disease, according to results of a phase-3 trial.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news